10X Capital Management, LLC (CIK 1457247) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-18). Recent activity: Sell GALT (24,000 shares), Sell GALT (30,681 shares), Sell GALT (30,000 shares), Sell GALT (132,069 shares), Sell GALT (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-18 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 24,000 | $0 |
| 2025-12-18 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 30,681 | $204,335 |
| 2025-12-08 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 30,000 | $164,100 |
| 2025-12-08 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 132,069 | $756,755 |
| 2025-12-04 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 30,000 | $164,100 |
| 2025-12-04 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 120,000 | $687,600 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 40,000 | $210,000 |
| 2025-10-24 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 20,000 | $98,600 |
| 2025-10-24 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 30,000 | $148,200 |
| 2025-10-10 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 21,323 | $65,248 |
| 2025-10-10 | GALECTIN THERAPEUTICS INC (GALT) | Insider | Sell | 3,677 | $11,252 |
Source: SEC Form 4 filings · as of 2025-12-18